Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.

Liu SS, Pickens S, Burma NE, Ibarra-Lecue I, Yang H, Xue L, Cook C, Hakimian JK, Severino AL, Lueptow L, Komarek K, Taylor AMW, Olmstead MC, Carroll FI, Bass CE, Andrews AM, Walwyn W, Trang T, Evans CJ, Leslie F, Cahill CM.

J Neurosci. 2019 Mar 12. pii: 0274-19. doi: 10.1523/JNEUROSCI.0274-19.2019. [Epub ahead of print]

PMID:
30862664
2.

Plasticity and Function of Spinal Oxytocin and Vasopressin Signaling during Recovery from Surgery with Nerve Injury.

Severino AL, Chen R, Hayashida K, Aschenbrenner CA, Sun H, Peters CM, Gutierrez S, Pan B, Eisenach JC.

Anesthesiology. 2018 Sep;129(3):544-556. doi: 10.1097/ALN.0000000000002290.

PMID:
29912007
3.

Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic.

Severino AL, Shadfar A, Hakimian JK, Crane O, Singh G, Heinzerling K, Walwyn WM.

Front Psychiatry. 2018 Apr 23;9:119. doi: 10.3389/fpsyt.2018.00119. eCollection 2018. Review.

4.

Regional differences in mu and kappa opioid receptor G-protein activation in brain in male and female prairie voles.

Martin TJ, Sexton T, Kim SA, Severino AL, Peters CM, Young LJ, Childers SR.

Neuroscience. 2015 Dec 17;311:422-9. doi: 10.1016/j.neuroscience.2015.10.047. Epub 2015 Oct 30.

5.

Gabapentin increases extracellular glutamatergic level in the locus coeruleus via astroglial glutamate transporter-dependent mechanisms.

Suto T, Severino AL, Eisenach JC, Hayashida K.

Neuropharmacology. 2014 Jun;81:95-100. doi: 10.1016/j.neuropharm.2014.01.040. Epub 2014 Feb 1.

Supplemental Content

Loading ...
Support Center